Our studies reveal the molecular mechanism explaining why HOXD-AS2 was specifically overexpressed in gliomas and provide a theoretical basis for the future of HOXD-AS2 as a potential molecular diagnostic marker. Here, HOXD-AS2 is linked to central nervous system cancer.